BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 10281338)

  • 1. Medical care at predetermined prices does not violate antitrust laws.
    Rothschild IS
    Health Law Vigil; 1987 Apr; 10(9):5-6, 12. PubMed ID: 10281338
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 3. Ball Memorial Hospital: Section 2 Sherman Act analysis in the alternative health care delivery market.
    Kirsch T
    Am J Law Med; 1988; 14(2-3):249-79. PubMed ID: 3072878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitrust charges fail to slow PPA action by insurer.
    Burda D
    Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
    [No Abstract]   [Full Text] [Related]  

  • 5. Vertical restraints among hospitals, physicians and health insurers that raise rivals' costs. A case study of Reazin v. Blue Cross and Blue Shield of Kansas, Inc. and Ocean State Physicians Health Plan, Inc. v. Blue Cross and Blue Shield of Rhode Island.
    Baker JB
    Am J Law Med; 1988; 14(2-3):147-69. PubMed ID: 3245541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrust issues in health care planning.
    Decker R
    Hosp Purch Manage; 1982 Feb; 7(2):14-6. PubMed ID: 10254100
    [No Abstract]   [Full Text] [Related]  

  • 7. Blues' discount policy seen as antitrust issue.
    Burda D
    Hospitals; 1986 Nov; 60(21):36. PubMed ID: 3770662
    [No Abstract]   [Full Text] [Related]  

  • 8. Court overturns jury's verdict on Blue Cross antitrust violation claim.
    Kazon PM
    Bus Health; 1988 Nov; 6(1):44-5. PubMed ID: 10290529
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust assault on hospital-Blue Cross relations.
    Davis CD
    Tex Hosp; 1984 Feb; 39(9):46-7. PubMed ID: 10278223
    [No Abstract]   [Full Text] [Related]  

  • 10. Provider suits against Blues sponsored PPOs prompt counterattack.
    Steele CJ
    Bus Health; 1985 May; 2(6):49. PubMed ID: 10271267
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitrust implications of "all-inclusive" payment methodologies: the Empire Blue Cross decision.
    Miles JJ
    Health Law Vigil; 1987 Jun; 10(13):5-7. PubMed ID: 10282184
    [No Abstract]   [Full Text] [Related]  

  • 12. Court decisions give Blues plans one win, one loss in separate antitrust cases.
    Halper HR; Kazon PM
    Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitrust threat dissolves PPO.
    Cain C
    Bus Insur; 1984 Oct; 18(44):2, 18. PubMed ID: 10278278
    [No Abstract]   [Full Text] [Related]  

  • 14. New face at the bargaining table.
    McCann RW; Tomaselli LA
    Hospitals; 1983 Oct; 57(20):75-9. PubMed ID: 6352455
    [No Abstract]   [Full Text] [Related]  

  • 15. "Blues interfered illegally with HMO.".
    Burda D
    Mod Healthc; 1987 Nov; 17(24):12. PubMed ID: 10284683
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred provider organizations: an antitrust warning.
    Sandler AL
    Group Pract J; 1987; 36(6):41-2, 44. PubMed ID: 10284861
    [No Abstract]   [Full Text] [Related]  

  • 18. Blue Cross and Blue Shield Plan contracts with providers: cost containment objectives amid conflicting legislative schemes.
    Heitler G; Ader M
    J Leg Med; 1981 Sep; 2(3):265-96. PubMed ID: 6976401
    [No Abstract]   [Full Text] [Related]  

  • 19. Toledo Hospital, Blue Cross plan in $2.5 billion suit.
    Robinson ML
    Hospitals; 1988 Aug; 62(15):28-9. PubMed ID: 3391564
    [No Abstract]   [Full Text] [Related]  

  • 20. Law-medicine notes: Health planning, Blue Cross, and the federal antitrust laws.
    Curran WJ
    N Engl J Med; 1981 Nov; 305(20):1194-5. PubMed ID: 6169992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.